Danaher Corporation $DHR Shares Sold by Toth Financial Advisory Corp

Posted by on Aug 29th, 2026

Toth Financial Advisory Corp lowered its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 32.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,442 shares of the conglomerate’s stock after selling 2,611 shares during the quarter. Toth Financial Advisory Corp’s holdings in Danaher were worth $1,036,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. High Note Wealth LLC lifted its stake in shares of Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares during the period. First Command Advisory Services Inc. grew its position in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after purchasing an additional 47 shares during the period. GW&K Investment Management LLC grew its position in shares of Danaher by 8.4% in the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after purchasing an additional 47 shares during the period. Kestra Private Wealth Services LLC increased its stake in Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, Gabelli Funds LLC lifted its position in Danaher by 0.3% during the fourth quarter. Gabelli Funds LLC now owns 18,981 shares of the conglomerate’s stock worth $4,345,000 after buying an additional 50 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

DHR opened at $216.41 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a 50 day moving average of $199.46 and a two-hundred day moving average of $192.52. The company has a market cap of $152.13 billion, a P/E ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. The firm’s revenue was up 5.5% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on DHR shares. Piper Sandler began coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Guggenheim dropped their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. HSBC cut their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

View Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.